Revenue: The sum of all revenue fields included for a company's operating activities.
ADC Therapeutics SA (ADCT) had Revenue of $16.79M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$16.79M |
$-85.70M |
|
$0.25M |
|
$16.54M |
|
$54.01M |
|
$-37.22M |
|
$3.11M |
|
$-34.11M |
|
$-34.11M |
|
$-80.17M |
|
$-85.70M |
|
$-85.70M |
|
$-80.17M |
|
$-37.22M |
|
$-36.21M |
|
81.71M |
|
81.71M |
|
$-1.04 |
|
$-1.04 |
|
| Balance Sheet Financials | |
$336.29M |
|
$5.62M |
|
$18.49M |
|
$354.78M |
|
$67.67M |
|
$112.73M |
|
$435.36M |
|
$503.03M |
|
$-148.25M |
|
$-148.25M |
|
$-148.25M |
|
82.29M |
|
| Cash Flow Statement Financials | |
$-118.69M |
|
$-3.22M |
|
$73.88M |
|
$326.44M |
|
$278.60M |
|
$-47.84M |
|
$13.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.97 |
|
-- |
|
-- |
|
-3.17 |
|
-0.76 |
|
98.49% |
|
-221.69% |
|
-221.69% |
|
-- |
|
-203.16% |
|
-510.44% |
|
$-121.90M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.02 |
|
0.67 |
|
134.98 |
|
57.81% |
|
57.81% |
|
-24.16% |
|
241.29% |
|
$-1.80 |
|
$-1.49 |
|
$-1.45 |
|